👩🔬Our Senior Scientist, Laura Caller, was invited to deliver a presentation on 3D genomics and her career in science. 🎤Laura spoke at the annual symposium for the University of Cambridge BBSRC School of Biological Sciences Doctoral Training Partnership, which took place at St John's College, Cambridge this year. 👩🎓Laura had a fantastic time engaging with the students and they were left inspired by her journey. 🧬We’re proud to be part of Cambridge’s vibrant ecosystem, where the synergy between industry and academia continues to drive innovation. #biotech #cambridge #3dgenomics #universityofcambridge
ENHANC3D GENOMICS’ Post
More Relevant Posts
-
Its great to inspire the next generation of scientists with the potential of 3D genomics and the work at ENHANC3D GENOMICS - well done Laura Caller! Our new case studies are demonstrating the impact of these critical chromosomal interactions for understanding biological mechanisms and accelerating drug discovery. The potential is huge, but if you want to understand the basics please check out our new animation - https://lnkd.in/eaC3_WF5
👩🔬Our Senior Scientist, Laura Caller, was invited to deliver a presentation on 3D genomics and her career in science. 🎤Laura spoke at the annual symposium for the University of Cambridge BBSRC School of Biological Sciences Doctoral Training Partnership, which took place at St John's College, Cambridge this year. 👩🎓Laura had a fantastic time engaging with the students and they were left inspired by her journey. 🧬We’re proud to be part of Cambridge’s vibrant ecosystem, where the synergy between industry and academia continues to drive innovation. #biotech #cambridge #3dgenomics #universityofcambridge
To view or add a comment, sign in
-
🌟 Discover the Bionoteam 🌟 We are delighted to introduce Gabriel Krouk, one of our three co-founders who is also our scientific director and a French CNRS researcher based in Montpellier. Gabriel brings a wealth of expertise in systems biology and machine learning to our team, focusing on solving the mysteries of nutrient-related signaling pathways in plant growth and development. His academic work has earned him three consecutive years as a highly cited researcher. 🔬 Gabriel's recent research has led us to explore various complex biological systems such as phenotypic responses and prediction to diverse environmental stress. His academic work is structured around a major objectives: Leveraging machine learning techniques to model genetic regulatory networks, decipher the effects of genetic variations on phenotypes, and design synthetic biological solutions. 🚀 Under Gabriel's visionary leadership, BionomeeX continues to explore scientific understanding in biology, paving the way for transformative advances in agriculture and biotechnology at large. www.bionomeex.com #Science #Plant Biology #Machine Learning #AI #Innovation
To view or add a comment, sign in
-
The 2024 Nobel Prize in Chemistry was awarded to three scientists for their groundbreaking work in protein science. David Baker received half of the prize for his pioneering work in computational protein design, which allows the creation of entirely new proteins with specific properties not found in nature. His work has broad applications, such as designing proteins to fight diseases like COVID-19. The other half of the prize was shared by Demis Hassabis and John Jumper for their development of AlphaFold2, an AI system that can accurately predict the 3D structure of proteins from their amino acid sequences. This breakthrough solved a decades-old challenge in biology and has revolutionized our understanding of how proteins work, with applications in fields ranging from medicine to environmental science. #proteins #sustainability #nobelprize
To view or add a comment, sign in
-
What's the strategy behind one of the most successful labs in the world? 🌍🔬 Chander Velu, from the Institute for Manufacturing (IfM), University of Cambridge, Luka Gebel and Toni Vidal-Puig MD PhD FRCP FMedSci MBA explore this question in a recent Nature Magazine article. The article uncovers the strategy behind the success of the MRC Laboratory of Molecular Biology (LMB) in #Cambridge, a leader in basic biology research 🧬. The LMB's impressive track record includes a dozen #NobelPrize winners and groundbreaking advancements in DNA structure, genetic sequencing, and cryo-electron microscopy, among others 🏆. The article highlights how the LMB’s unique #management model fosters #innovation by integrating high-risk basic science with cutting-edge technology 🚀. The authors conducted in-depth interviews and analysed decades of archival documents to uncover how LMB’s strategic approach could serve as a blueprint for other research organisations. Their findings emphasise the importance of #culture, #incentives, and #management oversight in creating a sustainable, high-impact research environment 🌟. 🔗 Read the full article here: https://lnkd.in/emvX8Gem. #Research #Innovation #Biology #ScienceLeadership #IFM #NaturePublishing #MRC #LMB Department of Engineering at the University of Cambridge University of Cambridge
To view or add a comment, sign in
-
Check out some of the elements of Nimbus Therapeutics’ secret sauce as explained by our own Daniel Price and Leela Sriram Dodda!
This week at the 23rd annual Bio-IT World Conference Expo organized by Cambridge Healthtech Institute our computational chemistry team had the opportunity to share their insights on the challenges of capitalizing on emerging technology such as modern AI/ML in drug discovery, and the role of computational chemists as drug discoverers. Many thanks to Leela Sriram Dodda, Ph.D., Director, Computational Chemistry, and Daniel Price, Ph.D., Vice President, Computational Chemistry & Structural Biology, who co-presented, “Harnessing Fully Pipelined ML-ADMET Models For Enhanced Molecular Design.” The presentation was recorded and will be available on-demand for conference participants. #BioITExpo
To view or add a comment, sign in
-
What I find particularly inspiring about our approach to research is that we rarely view it solely as something confined to a lab or as merely an intellectual exercise. Our research, exemplified by this conference, always considers the social impact as well. The notion that research can have a transformative impact on the country is a point that is perhaps extremely important right now. As a university, we aspire to contribute to basic research, to applied research, to translational research, and to build the second generation of researchers. - Dr. Ananya Mukherjee, Vice Chancellor of Shiv Nadar University, delivering remarks at the inauguration ceremony of the Genomics Conference 2024. #GIC2024
To view or add a comment, sign in
-
Your Futurelab has a new face 🙌 This page will continue running under the name xyna.bio. But that does not mean that our vision has changed! We remain strong in our strive to revolutionize bioinformatics by combining hyperautomation and intuitive design to harness the power of interdisciplinary research. Together, we will rethink the collaboration between computational scientists and wet lab bioscientists. Connect the node and follow us to stay up-to-date with how the future of science will look like! 🚀 #computationalbiology #xynabio #bioinformatics #science #iGem
To view or add a comment, sign in
-
Discover the biology of disease with Peter van der Spek “It is very important that things that are being discovered in academics are being converted into business.” It is the collaboration between companies, research and knowledge institutions, and the government that makes Rotterdam a breeding ground for the many medical innovations that are developed here and find their way to patients worldwide. Professor in Bioinformatics at Erasmus MC, Peter J. van der Spek, knows firsthand the importance of collaboration in advancing medical research. Let him convince you to work together. Watch the full interview here: https://lnkd.in/eAwX89Pr #RotterdamGenomics #LifeSciences #DNAResearch #MedicalInnovation #Collaboration
To view or add a comment, sign in
-
Exciting Announcement! I am honored to be invited to speak at the prestigious Conference on Structural Biology and Drug Discovery (CSBDD), organized by the Department of Biotechnology, SBE, SRM IST, in honor of the 102nd birth anniversary of the legendary Prof. G. N. Ramachandran, FRS—a pioneer whose work revolutionized our understanding of molecular structures. Mark your calendars for Day 2: October 9, 2024, where I will be delivering a talk on the Synergy of Bioinformatics and Emerging Technologies. This conference is an unparalleled opportunity to not only celebrate the scientific heritage of Prof. Ramachandran but also explore the future of research and development in structural biology. Whether you are a researcher, a biotech enthusiast, or a student eager to learn, this event is a platform for all to engage, learn, and inspire. Join us as we explore the cutting-edge advances and applications shaping the future of drug discovery and structural biology. Don’t miss this opportunity to connect, collaborate, and celebrate the incredible legacy of Prof. G. N. Ramachandran, whose contributions have left a lasting impact on the scientific community. Take a moment to read about the conference: https://lnkd.in/g4KHK4PC Looking forward to insightful discussions and networking with thought leaders in the field. I sincerely thank RV College Of Engineering for encouraging me. #CSBDD2024 #Bioinformatics #EmergingTechnologies #StructuralBiology #DrugDiscovery #ScienceForTheFuture #ProfGNRamachandran #ScienceInnovation
To view or add a comment, sign in
-
𝐈𝐬 𝐂𝐨𝐦𝐩𝐮𝐭𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐁𝐢𝐨𝐥𝐨𝐠𝐲 𝐑𝐞𝐩𝐥𝐚𝐜𝐢𝐧𝐠 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐲 𝐖𝐨𝐫𝐤? Not at all! Computational biology is revolutionizing research, but it's not replacing the essential role of hands-on laboratory experiments. Together, they form a dynamic synergy. Models and simulations drive predictions, while experiments breathe life into those predictions, validating and advancing scientific discoveries. Let's embrace both for innovative breakthroughs in science! #ComputationalBiology #LabResearch #Innovation #ScienceAndTech #Biotech
To view or add a comment, sign in
3,376 followers